# Prevenar (13v) Infant Drug Use Investigation

> **NCT02119104** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1087 (actual)

## Conditions studied

- Infants

## Interventions

- **DRUG:** Prevenar (13v)

## Key facts

- **NCT ID:** NCT02119104
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 1087 (ACTUAL)
- **Last updated:** 2017-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02119104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02119104, "Prevenar (13v) Infant Drug Use Investigation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02119104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*